Shares of Pfizer edged lower in premarket trading on Tuesday, even after the drugmaker reported fourth-quarter earnings and revenue that exceeded Wall Street expectations.
Pfizer (PFE) announced on Monday that it will acquire weight-loss drug developer Metsera (MTSR) in a deal valued at up to $4.9 billion, aiming to strengthen its foothold in the rapidly growing obesity treatment market.
03 Feb 2026-16:51
22 Sep 2025-15:47
